Back to LLY

Rhenman & Partners Asset Management AB → LLY

Rhenman & Partners Asset Management AB LLY Position History

Eli Lilly and Company • Healthcare

Quarters held
4
Latest value
$21.8M
Q3 2026
Peak value
$45.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$45.4M
Q1 2026$31M
Q2 2026$26.8M
Q3 2026$21.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$21.8M18.9K——
Q2 2026$26.8M22.3K——
Q1 2026$31M33.7K——
Q4 2025$45.4M42.2K——

Other funds holding LLY

Other Rhenman & Partners Asset Management AB positions

REGN

REGENERON PHARMACEUTICALS

$47.4M
BSX

BOSTON SCIENTIFIC CORP

$41.1M
BSX

BOSTON SCIENTIFIC CORP

$39.2M
UNH

UNITED HEALTH GROUP INC

$38.9M
REGN

REGENERON PHARMACEUTICALS

$37.2M
JPM-PM

IOVANCE BIOTHERAPEUTICS INC

$37.1M
AZN

ASTRAZENECA PLC

$30.3M
MRK

MERCK & CO. INC

$30.1M